Bioptimus
L7 · Models
scientific & causal modelsstartupprivateseed
Open weight
Bioptimus trains general-purpose biological foundation models across tissue images and other biological modalities, building reusable representations for drug discovery, diagnostics and research. It released H-optimus-0 publicly in 2024 and followed with larger checkpoints across 2025-2026.
Ecosystem functionBuilding reusable multimodal representations of human biology rather than models for one therapeutic target.
Business modelBiology foundation models
Revenue—
Valuation—
Last round$41Mled by Cathay Innovation · 2024
Sources · 1 ↓
Suggest an editLast verified 2026-08-07